These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34697401)

  • 1. Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature.
    Brydges CR; Fiehn O; Mayberg HS; Schreiber H; Dehkordi SM; Bhattacharyya S; Cha J; Choi KS; Craighead WE; Krishnan RR; Rush AJ; Dunlop BW; Kaddurah-Daouk R;
    Sci Rep; 2021 Oct; 11(1):21011. PubMed ID: 34697401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics Signatures of serotonin reuptake inhibitor (Escitalopram), serotonin norepinephrine reuptake inhibitor (Duloxetine) and Cognitive Behavior Therapy on Key Neurotransmitter Pathways in Major Depressive Disorder.
    Bhattacharyya S; MahmoudianDehkordi S; Sniatynski MJ; Belenky M; Marur VR; Rush AJ; Craighead WE; Mayberg HS; Dunlop BW; Kristal BS; Kaddurah-Daouk R;
    medRxiv; 2024 Apr; ():. PubMed ID: 38633777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Synbiotic Treatment on the Levels of Gut-Derived Uremic Toxins, Inflammation, and Gut Microbiome of Chronic Kidney Disease Patients-A Randomized Trial.
    Mitrović M; Stanković-Popović V; Tolinački M; Golić N; Soković Bajić S; Veljović K; Nastasijević B; Soldatović I; Svorcan P; Dimković N
    J Ren Nutr; 2023 Mar; 33(2):278-288. PubMed ID: 35995418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease.
    Lin X; Liang W; Li L; Xiong Q; He S; Zhao J; Guo X; Xiang S; Zhang P; Wang H; Ying C; Yao Y; Zuo X
    J Ren Nutr; 2022 Sep; 32(5):578-586. PubMed ID: 34736844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial.
    Ebrahim Z; Proost S; Tito RY; Raes J; Glorieux G; Moosa MR; Blaauw R
    Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease.
    Nazzal L; Roberts J; Singh P; Jhawar S; Matalon A; Gao Z; Holzman R; Liebes L; Blaser MJ; Lowenstein J
    Nephrol Dial Transplant; 2017 Nov; 32(11):1809-1817. PubMed ID: 28379433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indole and indoxyl sulfate, gut bacteria metabolites of tryptophan, change arterial blood pressure via peripheral and central mechanisms in rats.
    Huć T; Nowinski A; Drapala A; Konopelski P; Ufnal M
    Pharmacol Res; 2018 Apr; 130():172-179. PubMed ID: 29287686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism-based inhibition of gut microbial tryptophanases reduces serum indoxyl sulfate.
    Graboski AL; Kowalewski ME; Simpson JB; Cao X; Ha M; Zhang J; Walton WG; Flaherty DP; Redinbo MR
    Cell Chem Biol; 2023 Nov; 30(11):1402-1413.e7. PubMed ID: 37633277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the gut microbial metabolic pathway with small molecules decreases uremic toxin production.
    Wang Y; Li J; Chen C; Lu J; Yu J; Xu X; Peng Y; Zhang S; Jiang S; Guo J; Duan J
    Gut Microbes; 2020 Nov; 12(1):1-19. PubMed ID: 33016221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An online atlas of human plasma metabolite signatures of gut microbiome composition.
    Dekkers KF; Sayols-Baixeras S; Baldanzi G; Nowak C; Hammar U; Nguyen D; Varotsis G; Brunkwall L; Nielsen N; Eklund AC; Bak Holm J; Nielsen HB; Ottosson F; Lin YT; Ahmad S; Lind L; Sundström J; Engström G; Smith JG; Ärnlöv J; Orho-Melander M; Fall T
    Nat Commun; 2022 Sep; 13(1):5370. PubMed ID: 36151114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis.
    Vanholder R; Nigam SK; Burtey S; Glorieux G
    Toxins (Basel); 2022 Mar; 14(3):. PubMed ID: 35324718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor-induced risk of chronic kidney disease is associated with increase of indoxyl sulfate synthesis via inhibition of CYP2E1 protein degradation.
    Lu S; Zhao J; Chen X; Xu S; Yang X; Zhang Y; Ma Z; Jiang H; Zhou H
    Chem Biol Interact; 2022 Dec; 368():110219. PubMed ID: 36243147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Gut Microbiome Signatures Associated with Indole Pathway in Tryptophan Metabolism in Patients Undergoing Hemodialysis.
    Huang JK; Wu PH; Chen ZF; Liu PY; Kuo CC; Chuang YS; Lu MZ; Kuo MC; Chiu YW; Lin YT
    Biomolecules; 2024 May; 14(6):. PubMed ID: 38927027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression-related anterior cingulate prefrontal resting state connectivity normalizes following cognitive behavioral therapy.
    Pantazatos SP; Yttredahl A; Rubin-Falcone H; Kishon R; Oquendo MA; John Mann J; Miller JM
    Eur Psychiatry; 2020 Apr; 63(1):e37. PubMed ID: 32284075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
    Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
    Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-focused brain predictors of cognitive behavioral therapy response in a transdiagnostic sample.
    Fang A; Baran B; Feusner JD; Phan KL; Beatty CC; Crane J; Jacoby RJ; Manoach DS; Wilhelm S
    J Psychiatr Res; 2024 Mar; 171():108-115. PubMed ID: 38266332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
    Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
    Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations Among Plant-Based Diet Quality, Uremic Toxins, and Gut Microbiota Profile in Adults Undergoing Hemodialysis Therapy.
    Stanford J; Charlton K; Stefoska-Needham A; Zheng H; Bird L; Borst A; Fuller A; Lambert K
    J Ren Nutr; 2021 Mar; 31(2):177-188. PubMed ID: 32981834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of tryptophan metabolites with connectivity of extended central reward network in healthy subjects.
    Osadchiy V; Labus JS; Gupta A; Jacobs J; Ashe-McNalley C; Hsiao EY; Mayer EA
    PLoS One; 2018; 13(8):e0201772. PubMed ID: 30080865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.